Trials & Tribulations Why infection and immunity matter for Florida’s cancer patients February 13, 2026Vol.52 No.06By Eduardo Sotomayor
Conversation with The Cancer Letter On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center February 06, 2026Vol.52 No.05By Paul Goldberg
NCI Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural researchThe group replaced the NCI Board of Scientific Advisors February 06, 2026Vol.52 No.05By Claire Marie Porter
Black History MonthPodcast Black History Month: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention“Trying to realize how good we actually could be if our system were truly efficient is what Otis is all about” February 06, 2026Vol.52 No.05By Robert A. Winn, Otis W. Brawley and Preston Willett
Guest Editorial The National Highway Traffic Safety Administration has a profound, albeit not immediately obvious, impact on cancer February 06, 2026Vol.52 No.05By Ken Kobayashi and Joan H. Schiller
PodcastThe Directors The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)Cancer centers fund small grants to boost morale amid low paylines January 30, 2026Vol.52 No.04By Paul Goldberg and Claire Marie Porter
Capitol Hill FY26 funding package blocked in Senate after ICE shooting of Alex PrettiNew package—likely excluding DHS—may go back to House early next week January 30, 2026Vol.52 No.04By Jacquelyn Cobb
FreeObituary Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42 January 30, 2026Vol.52 No.04
FreeTrials & Tribulations Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore January 30, 2026Vol.52 No.04By Les Biller
Sponsored Antibody halts triple-negative breast cancer in preclinical models January 30, 2026Vol.52 No.04By Hayley Kamin
